You are invited: HIVE Webinar with Dr. Gordon Sussman, Thursday, June 25 at 7:00AM EST on “Chronic Urticaria: New Understanding of an Old Disease”

EVENT: HIVE webinar #1 with Dr. Gordon Sussman

DATE/TIME: Thursday, June 25th at 07:00AM EST

TITLE: Chronic Urticaria: New Understanding of an Old Disease


  • To review clinical presentation and differential diagnosis
  • To update new guideline in chronic urticaria
  • To update new understanding in pathophysiology
  • To update new treatment in chronic urticaria


Step 1: Join the audio portion – Dial toll free 1-866-830-9434 then enter participant code 7994216

Step 2: Join the web portion by clicking this link, enter your name and then enter as a guest:


If you have never attended an Adobe Connect meeting before:

Test your connection:

Get a quick overview:

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

Dernières initiatives et développements en urticaire: Entrevue de 6 minutes avec le Docteur Jaime Del Carpio, Université McGill

>> Voir le vidéo de Dr Del Carpio

Cette vidéo eXtract présente les points saillants de la conférence sur l’urticaire tenue en 2019 par les centres UCARE (Urticaria Centers of Reference and Excellence) et le réseau GA2LEN (Global Allergy and Asthma European Network). Dans ce bref survol, un expert s’attarde sur les progrès réalisés dans la prise en charge de l’urticaire chronique spontanée (UCS). Aux initiatives visant à accroître la sensibilisation sur cette maladie et sa grande nocivité pour la qualité de vie quand elle n’est pas traitée viennent maintenant s’ajouter des programmes créés pour mieux caractériser la maladie et perfectionner les stratégies thérapeutiques.

[ Also available in English]


Launch of the HIVE Community

We’re pleased to announce the launch of a new initiative called Health Innovation Virtual Engagement (HIVE), an online learning community for Canadian physicians with an interest in urticaria and related conditions.

HIVE will foster open scientific discussions through online forums, webinars and micro-learning objects, to sustain ongoing connection anchored in scientific discovery and expert insight. It is our hope that this enhanced collaboration will advance understanding in this field and support the highest level of care in Canada.

Members of HIVE will receive a weekly email digest with a summary of newly-released scientific articles from HIVE members, curated content from sources identified by the HIVE faculty, as well as periodic learning opportunities including: (a) structured questions to initiate forum discussions, (b) article reviews via podcast and/or webinars, and (c) polling questions and webinars to augment community discussions. The webinars will be recorded and archived as enduring learning material for community use.

LegitiMed will be managing this virtual community residing on Sosido ( 

We understand your level of participation will be determined by your level of interest. As such, if you find that the network is not useful to you or you do not want your research to be featured, you can unsubscribe at any time (see unsubscribe instructions below).

We are interested in a full exchange of ideas around this subject. So, if you know others who would be interested in participating in the HIVE community, we welcome your referrals/recommendations.

We thank Novartis Canada for their financial support of this initiative.

We look forward to hosting you.


Dr. Gordon Sussman, MD, FRCP(C), FACP, FAAAAI
Chair, HIVE